Prostatic arterial embolisation: outcomes at a UK tertiary referral centre
BAUS ePoster online library. Johnstone C.
Jun 27, 2018; 211365
Mr. Christopher Johnstone
Mr. Christopher Johnstone
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction: Innovation in surgery and the need for less invasive therapeutic options with reduced side effects have driven the advent of minimally invasive procedures for the treatment of benign prostatic hyperplasia (BPH). Prostatic Arterial Embolisation (PAE) has been proven to reduce prostatic volume resulting in symptomatic improvement.

Patients and Methods: We report findings from a prospective study of PAE outcomes from May 2015 to December 2017 at a UK tertiary centre. Follow up IPSS score was compared using a T-Test.

Results: 27 patients (mean age 64yrs) were analysed. Main indication was minimal invasiveness and preservation of erectile function. 25 (92%) had received maximal medical therapy. Mean IPSS and QOL scores pre-procedure were 23 and 4. Average Qmax was 9mls/s and mean post-void residual urine volume was 135mls. 3 patients had long term catheters. 10 patients had urodynamically proven obstruction. 24 (89%) had bilateral PAE (3 unilateral). Follow up MRI at 3 months showed a mean volume reduction of 18% (96mls to 79mls). There have been no significant reported complications. At follow-up 70% of patients reported improvement in symptoms with a mean IPSS score 11, representing a 52% reduction (P < 0.001). A 50% improvement (mean 2) in QOL was also reported.

Conclusions: PAE is a safe and minimally invasive option for the treatment of BPH. 18% volume reduction is seen at 3 months on MRI. During follow up 70% of patients have reported symptom improvement with a mean reduction of 12 points (52%) in IPSS score compared to pre-procedure scores.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings